𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Attenuated immunochemotherapy for diffuse large B-cell lymphoma – Authors' reply

✍ Scribed by Frédéric Peyrade; Fabrice Jardin

Book ID
117785729
Publisher
The Lancet
Year
2011
Tongue
English
Weight
70 KB
Volume
12
Category
Article
ISSN
1470-2045

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic models for diffuse large b-ce
Prognostic models for diffuse large b-cell lymphoma
✍ Annarita Conconi; Emanuele Zucca; Enrico Roggero; Francesco Bertoni; Augusto Ber 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

Prognosis of DLCL patients is variable and associated with well-de®ned risk factors. In the past decade several pretreatment variables have been incorporated into prognostic models to predict the death risk of individual patients. The International Prognostic Index (IPI), developed in an internation

P129 Immunochemotherapy of diffuse large
P129 Immunochemotherapy of diffuse large B-cell lymphoma in a patient with systemic lupus erythematosus
✍ Zs. Simon; Zs. Ress; L. Gergely; T. Tarr; E. Kiss; Á. Illés 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

A total of ten patients died, seven due to progressive disease, two due to unrelated cause, and one due to febrile neutropenia. In mantle zone lymphoma the R in combination with fludara (F) and cyclophosphamide (C) resulted CR lasting for 16 months. The patient with CLL is in CR after R-F-C. Conclus